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Abstract: A method of encasing cardiovascular stents with an expandable polyurethane 
coating has been developed to provide a smooth homogeneous inner wall allowing for a 
confluent growth of endothelial cells. In this design, the metal wire stent structure is 
completely covered by the polyurethane film minimizing biocorrosion of the metal 
(stainless steel or nitinol), and providing a homogeneous surface for surface treatment 
and incorporation of various eluting drugs to prevent platelet aggregation while 
supporting endothelialization. The polyurethane surface was treated with a helium 
plasma for sterilization and promotes growth of cells. The paper details the 
performance of the coated film to expand with the metal stent up to 225 % during 
deployment. We present stress/strain behavior of polyurethane films, and subsequent 
plasma treatment of the surface and the adhesion of the coating to the stent structure 
upon expansion. A film of less than 25 tm was found to be sufficient for corrosion 
resistance and flexibility without producing any excess stress on the stent structure. 
Straining the film to 225 % and plasma modification did not affect the mechanical and 
surface properties while allowing for improved biocompatibility as determined by the 
critical surface tension, surface chemistry, and roughness. 
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INTRODUCTION
Regrowth of the atherosclerotic plaque and reblocking (reclusion or restenosis) of the artery 
after percutaneous transluminal coronary angioplasty (PCTA) can occur soon after the 
procedure, occurring in about 15 - 30 % of patients receiving cardiovascular stents.' 
Restenosis is due primarily to neointimal hyperplasia. 2 The stent also causes injury to the
endothelium which can cause inflammation and consequent smooth muscle cell growth. 3 To
prevent restenosis, various techniques involving coating stents with anti-thrombotic drugs
have been deployed." 4-6 There are two main types of stents that are in use today; balloon-

expanding and self-expanding. Balloon-expanding stents are commonly manufactured from 
31 6L stainless steel, and the self-expanding ones from an equi-atomic nickel-titanium (NiTi) 
alloy also known as nitinol. The material of choice at present is 31 6L stainless steel, but 
there is a recent trend towards nitinol stents. 7 Numerous studies have been performed on the 
biocompatibility of both 316L stainless steel and NiTi. 8 '° 3 16L stainless steel (Ni 14 wt. 
%) is generally accepted as an implant material, but due to the high nickel content of NiTi 
alloy (Ni '- 45 wt. %), concern exists regarding the release of Ni 2 ions into the body that can
cause severe cellular inflammation and become a possible carcinogen over long term 
exposure." However, finishing surface treatments such as electropolishing and passivation, 
and heat treatment have been shown to provide an acceptable biocompatible surface finish 
for NiTi.'2'3 
The present strategy has been to use various polymers, and then incorporate the drugs 
into the polymer matrix to prevent growth of underlying smooth muscle cells. Unfortunately, 
most polymers are not blood compatible and can cause an intense inflammatory response in 
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the artery.' 4 Polyurethanes have been extensively used in biomedical research' 5 and offer 
excellent mechanical properties and biocompatibility. Biologically active endothelial cells 
have the inherent property of inhibiting platelet aggregation, inflammation and inhibiting 
smooth muscle cell growth. 
In order to provide a homogeneous endothelial cell lining on the inner wall of the 
encased stent, it will be necessary to provide a blood-compatible surface for growth of a 
bioactive endothelial cell lining to provide such antithrombegenic properties such as release 
of prostacyclin and NO emission and thrombomodulin. All stents in current use are based on 
an open-cell mesh structure that is expandable, but this open cell structure does not allow for 
a continuous and smooth endothelial cell lining. In order to have a homogeneous endothelial 
cell lining, a continuous film rather than a mesh may be preferred. A thin polymer coating 
that encases the metallic stent for rapid endothelialization has been developed by our group 
(Figure l) . 16 ChronFlex AR®, a medical grade polyurethane from Cardiotech International, 
Wobum, MA, was chosen for use. This polyurethane exhibits superior corrosion resistance 
and stress-cracking under harsh environments (the human body). It has an elongation of 500 
% and tensile strength of 57 MPa and is considered ideal in applications requiring 
exceptional flexure endurance. 17 Previous work by Mazumder et al.' 8 showed that a 30 jim 
thick coating of this polyurethane significantly reduced the corrosion susceptibility of NiTi in 
Ringer's solution. The most important requirement of the choice of the film encasing the 
stent is to support a bioactive confluent endothelial cell growth and the adhesion of the cell 
lining with the film surface under the physiological flow conditions. In a parallel study, the 
endothelial cell growth properties were investigated for this encased stent design and was 
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reported by De at el.' 9 The study also showed that modification of the polyurethane film 
surface by helium plasma treatment enhanced the endothelial cell growth compared to 
untreated film. 
A polymer film encasing a stent has to be a radially and uniformally expandable during 
angioplasty, and it must retain its integrity once expanded within the artery for its lifetime. 
The radial expansion and physiological performance of the polymer coating depends upon 
both the stent material and the film used. 
A stent, encased or open cell-structured, may be considered a tube that is expanded by 
pressure. Pressures applied to any cylindrical structure result in hoop stress, or 
circumferential-loading of the tube. Both the applied pressure and the resulting hoop stress 
have the same units but differ in direction, as shown in Figure 2. 
The hoop stress (a) is given by:2°
(1) 
where 4 is the tube diameter and t the coating wall thickness. The hoop force in the coating 
wall is given by:2'
F9atL	 (2) 
Where L is the length of the tube. The hoop force per unit length of the tube is: 
f9 =F9/L=atP4il2	 (3) 
In the case of encased stents, the hoop force is of interest as it relates to the strength or 
maximum hoop load that can be carried by the film without failure. Failure would occur 
when the hoop stress exceeds the ultimate tensile strength (UTS) of the polymer coating. 
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The stiffness of the stent is an important quantity as it describes the effectiveness of the 
stent in resisting diameter loss once expanded, the balloon is removed and the stent is 
subjected to the blood vessel recoil. The stiffness is defined as the hoop force per unit length 
required to elastically change its diameter, given by; 
K9 = f9/d4)	 (4) 
Where d4) is the differential increment of the diameter 4). 
Self-expanding stents are typically manufactured at the vessel diameter or slightly 
greater, and then crimped until used. Upon delivery to the vessel, the constraint is removed. 
A balloon is still deployed, but the self-expansion of the SMA assists the balloon expansion, 
compared to that of a stainless steel balloon-expandable stent that resists the balloon's 
expansion 
The detailed behavior of the interaction of the balloon and self-expanding stents with the 
arterial wall during deployment has been investigated by Duerig et al.21 '22 In both cases, 
once the balloon is deflated, the vessel and stent recoil to establish a final stress equilibrium 
which depends upon the stent's stiffness, otherwise, further recoil would occur. In the 
examples given, for a 4 mm balloon-expandable stent expanding to 9 mm in a 7 mm vessel, 
and for a 10.5 mm long self-expanding stent that was crimped and expanded in a 7 mm 
vessel, the hoop force at the final equilibrium point is approximately 0.11 N/mm. 22 Dynamic 
effects after deployment due to the diastolic and systolic pressures cause variations of the 
equilibrium force up to +1- 0.06 N/mm.2 ' A cross-section of an expanding stent is shown in 
Figure 3. Here the coating and stent struts are expanded by the balloon from diameter a to b. 
Upon deflation of the balloon, the hoop stress and the arterial wall stress compress the stent
and coating back to diameter C. With the balloon now not supporting the coating film, it will 
be likely to minimize strain by flattening out as shown with residual stresses acting in tension 
upon the stent framework. 
Using the examples above, an encased stent with a diameter of 4 mm, and expanded to 9 
mm, the polymer film would, therefore, undergo an expansion of 225 % with a residual strain 
of 206 % after recoil. It is, therefore, of great importance that the polymer coating is able 
to withstand that strain and retain its integrity once expanded without causing acute recoil of 
the stent. Similarly, the film will have to retain its bond to the stent metal structure under 
strain for its lifetime. The bond strength or film adhesion, therefore, plays an important role. 
In addition, the final surface structure of the inner wall of the encasing film needs to be 
suitable for the adhesion of the endothelial cell lining. The surface roughness and wettability 
of the film after expansion and recoil needs to be addressed. Also, any effect of the surface 	 - 
modification such as plasma treatment, necessary for endothelial cell linings, on the surface 
chemistry and topography needs to be investigated. 
Experimental studies were performed to characterize the polyurethane for use as an 
encased stent coating. Experimental data are presented on: The stress/strain behavior of the 
polyurethane coating strained to 225 % elongation, 2) the adhesion of the coating to a stent 
wire upon expansion, 3) the surface structural changes caused by the expansion, and, 4) The 
effect of surface chemistry and surface structure and wettability of the polyurethane film 
after surface plasma modification and expansion. 
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EXPERIMENTAL METHODS 
Stress/strain behavior of polyurethane films 
Thin films of ChronoFlex® AR polyurethane were prepared on polytetrafluoroethylene 
(PTFE) flat sheets by dip coating and leaving the films hanging to dry at 60 - 80 °C for 24 
hours. By this method, films as thin as 30 p.m can be prepared. Repeated dip coatings 
prepared films of various thicknesses. When cured, the films were then easily peeled off the 
PTFE. Strips of film 50 mm in length and 6 mm in width were cut out. The thickness of 
each strip was measured at ten points using a Fischer Instruments Permascope eddy current 
probe and the mean value taken. Tensile (stress/strain) tests were performed (ASTM D-412 
standard) in an Instron 5500R equipped with an environmental chamber. The films were 
tested at 37°C to simulate body temperature at a strain rate of 5 mmlmin. The films were 
strained to 225 % as measured by a video extensometer set up outside the environmental 
chamber. At 225 % strain, the film was unloaded at -5 nimlmin until the applied load 
reached zero. 
Effect of strain on the surface chemistry of the polyurethane coating, 
Helium plasma surface modification 
Plasma treatment was carried out on polyurethane films prepared as above in an atmospheric 
plasma generator consisting of a 90 cm long cylindrical Pyrex tube with an inner diameter of 
3 cm, with copper electrodes (7.5 cm x 3 cm) placed on either side of the cylinder. The inlet 
to the cylinder was connected to a gas flow regulator, and the outlet to a vacuum (-.4 02 ton). 
-.	
The thin polyurethane films of approximately 70 mm in lengtl and 10 mm in width were 
placed onto PTFE sheets inside the cylinder within the electrode region, as shown in Figure 
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1. The electrodes were capacitively coupled to a power source of 12 kVrms at a frequency of 
700 Hz. Helium was introduced into the tube until a characteristic glow was observed. The 
films were exposed for 4 and 6 minutes. 
XPS analysis 
Two sets of thin polyurethane films were prepared on 22 mm square glass slides that were a 
suitable size for submission into the ESCA spectrometer. One set was helium plasma treated 
for 4 and 6 minutes. The XPS data were obtained on a Kratos Axis ESCA Spectrometer 
using a Mg Ka (hv 1253.6 eV) x-ray source. The x-ray beam used was 100W, 100 mm in 
diameter. The collected data were referenced to Au at 84.0 +1- 0.05 eV and the Cis peak to 
284.6 eV. The high-resolution scans of the Cis peaks were acquired at a pass energy of 40 
eV, in 0.2 eV steps with a 3000 ms dwell time. The relative atomic concentrations of the 
detected elements were calculated and nonnalized to 100% using sensitivity factors supplied 
by the instrument manufacturer from known certified standards. Detection limits for XPS are 
approximately 0.05 to 1.0 atomic % depending upon the sensitivity of the elements. The 
individual element spectra were converted to ASCII format and imported to a computer 
where the peak curve fitting was performed using Thermo VG Scientific Eclipse V3.0 XPS 
data reducing software. 
Surface wettability measurements 
In general, there are three macroscopic properties of a surface of a solid containing more than 
one chemical element: the surface tension, the surface stress, and the specific surface free 
energy.23 The surface tension y is defined as the reversible work done in creating a unit area 
of new surface at constant temperature, volume and total number of molecules. For a solid
undergoing an isotropic strain, it will not deform isotropically as some directions on the 
surface will deform more easily than others; therefore, the surface tension will vary with the 
strain. The surface roughness will also change under strain due to the flattening out of the 
peaks and valleys, and it is well known that surface roughness is also a factor on the surface 
tension24 The critical surface tension ('yci-it), as defined by Zisman, 25 is that in which the liquid 
has a surface tension equal to, or less than, the value required to completely wet and spread 
spontaneously on the surface. Baier 26 established a correlation between the critical surface 
tension and thrombogenicity in which there is a region of minimum Ycrit where biological 
interaction between the body and the biomaterial is at a minimum 
A small platform was designed in which a length of polyurethane film can be strained to 
different amounts and clamped, as shown in Figure 5. A VCA-optima Surface Analysis 
System was used for contact angle measurements. Contact angle measurements of a 
homologous series of organic liquids were used to estimate the critical surface tension of an 
untreated polyurethane surface.27'28 The critical surface tension was obtained by carrying out 
contact angle (0) measurements for different liquids and extrapolating the data to cos 0 1. 
Calibration of the VCA Optima instrument was conducted using a PTFE substrate and de-
ionized water under ambient conditions (50 % RH, 20-25 C). The PTFE surface was 
cleaned sequentially with acetone, methanol, and distilled water. The cleaned PTFE was 
preserved in a hot air oven. De-ionized water droplets were generated on the PTFE surface 
using a Hamilton-make syringe. The droplet volume varied from 4 to 5 micro-liters. Images 
of droplets were acquired immediately On cOntact of the droplet with the PTFE surface. Each 
time five markers were placed around the droplet image and both right and left angle images 
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were calculated using the software. This process was repeated until the difference between 
the right and left angles was found to be minimum (< 1°). The series of homologous organic 
liquids with their- respective surface tensions 27 '29 used for generating the Zisman plots were; 
de-ionized water (72.8 dynes/cm), glycerol (64.0 dynes/cm), ethylene glycol (47.7 
dynes/cm), formamide (58.2 dynes/cm), and benzene (28.88 dynes/cm). The contact angle 
experiments on plasma-treated polyurethane were carried out immediately after the surface 
treatment. 
Adhesion of the coating to the stent wire mesh upon expansion 
Once a stent is implanted and expanded, the strained coating has to hold its integrity. As 
shown earlier in Figure 3 at the final equilibrium point C, the coating will be under tension by 
the struts of the stent framework. The forces have to be in balance so that there is no 
delamination of the coating from the metal. At present, stents are electropolished as their 
final finish, which produces a very smooth, corrosion-resistant surface, but if the stents are to 
be totally encapsulated, then this smooth surface may no longer be needed. In order to test 
the performance of a simulated coated stent, a model was made for testing in the Instron. A 
stainless steel wire of 500 jim diameter, was threaded on a jig to form an expandable pattern, 
as shown in Figure 6. The wire was placed on a pre-prepared thin polyurethane film (50 
jim), and re-coated with polyurethane. High magnification optical images were taken of the 
wire coating integrity before elongation (Figure 7), where it can be seen that the coating was 
uniform even around the curves of the wire. The total film thickness of the coating between 
the wire struts was measured at approximately 125 jim. An optical microscope with a video 
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camera was set up outside the environmental chamber so that the induced strain was recorded 
during the tensile test
RESULTS AND DISCUSSION 
Stress/strain behavior of polyurethane film 
Stress/strain experiments performed on polyurethane films of different thicknesses are shown 
in Figure 8. lii these experiments, the films were loaded to 255 % strain, and then unloaded 
to zero load. In this plot the unloading strain is not shown for clarity. 
The stress was plotted as the force per mm width of the film to correspond with the hoop 
stress for a coated stent. The stress required to strain each film to 225 % was plotted as a 
function of film thickness, and is shown in Figure 9. Extrapolation of the plot showed that 
for a maximum stress (e.g. for a 4 mm balloon-expandable stent expanding to 9 mm in a 7 
mm vessel) of approximately 0.11 N/mm the film thickness was - 25 - 30 tm. As previously 
shown by Mazunider et al,' 8 a 30 pm polyurethane film showed a significant reduction in the 
corrosion susceptibility of NiTi as used in self-expanding stents. 
Another observation from the stress/strain curves was that a residual strain of up to 25 % 
remained in the films after unloading. This may be attributed to the disruption of the hard 
segments in the polymer. The chemistry of the hard and soft segments and the degree of 
phase separation can significantly affect the stress/strain behavior. Hard segment 
crystallization has been found to increase this hysteresis of the stress/strain curves. 15 Work 
by Amitay-Sadovsky et al 30 showed that the elastic properties of a polyurethane surface is 
different from that of the bulk for small strains (10 - 20 %), but at higher strains (>100 %) 
the surface elastic modulus increased along with a decrease in the surface roughness. It was 
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suggested that randomly oriented hard segments migrate to the surface upon stretching 
leading to an increase in the hard-to-soft segment concentration and causes a decrease in the 
surface roughness 3° Phase imaging using Atomic Force Microscopy (AFM) of two 
components in a similar polyurethane film was shown by De et a!19 and clearly showed the 
distribution of the two segments due to differences in stiffness. 
Effect of strain on the surface chemistry and wettability of the polyurethane coating 
XPS analysis 
XPS data of the carbon peak of polyurethane before and after plasma treatment are shown in 
Figure 10, and the peak summary is presented in Table 1. Peaks were identified at 284.6, 
285.5, 286.5, 288.2, 290.0, and 290.5 eV, corresponding to C-C/C-H, C-N, C-O, C=O, 0-
CO, and it-t bonding. 3 ' 33 From the data it was observed that there were only minor 
changes after plasma treatment. There was a decrease in the C-C/C-H bonding and an 
increase in the C=0 bonding indicating an increase in the oxidation of the surface. The 
synthesis of the ChronoFlex AR is carried out by the addition of MDI to polycarbonate diol, 
with the addition of a mixture of chain extenders and a molecular weight regulator, of which 
the composition of the latter two are unknown. Therefore at the present, it is difficult to get 
an accurate interpretation of the relevance of the plasma induced surface changes from the 
XPS data. However, identification of the surface functional groups in correlation with 
surface tension data can enable the amount of hydrophilicity to be determined. 
Surface wettability 
The Zisman plot of untreated polyurethane and PTFE is shown in Figure 11. The critical 
surface tension (Ycnt) of PTFB was measured at 20.5 dynes/cm, which is in good agreement 
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with reported values of 18.5 - 22 dynes/cm, 3° and that of the untreated polyurethane was 
measured at 27 dyneslcm which is within the zone of biocompatibility. The Zisman plot of 
untreated polyurethane as received and strained to 100 % and 225 % elongation is shown in 
Figure 12, where the critical surface tension was observed to only increase slightly even for 
225 % elongation to 29 dynes/cm, and still within the zone of biocompatibility. It is 
interesting to observe that the data for the 100 % elongation showed higher values for cos 0, 
i.e. lower contact angles and hence more hydrophilicity, than for the 225 % elongation film. 
This is at present unexplained and wanants further investigation. The Zisman plot for 
untreated and plasma treated films as received and strained to 225 % elongation is shown in 
Figure 13. Again it was observed that both the plasma treatment and straining the films 
caused the hydrophilicity to increase, but the critical surface tension was still <30 dynes/cm, 
within the zone of biocompatibility. 
Adhesion of the coating to the stent upon expansion 
Images of part of the wire taken at various points in the test up to 50% strain and on 
unloading are shown in Figure 14. Stretching of the polyurethane film from the wire was 
first observed at 13.3 % strain. It appears to be pronounced around a bend in the wire. At 50 
% strain, slight separation from the wire is also observed on a straight part of the wire that 
was not seen in earlier images. Upon unloading, a marked delamination region was bserved 
at 20 % strain; however, this is not so pronounced upon complete unloading (0 %), and the 
coating appears similar to before the test. As an encased stent is expected to have an 
improved wire-to-film adhesion, then a plasma or chemically treated stent will be used. 
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CONCLUSIONS 
A method of encasing cardiovascular stents with a radially expandable polyurethane film is 
developed for its potential application to minimize restenosis. Stress/strain tests show a film 
< 30 tm thiclthess is sufficient to prevent re-collapse of a balloon or self-expanding stent. 
Plasma modification and straining polyurethane films to 225 % does not affect critical 
surface tension, within the zone of biocompatibility, but showed a slight increase in 
hydrophilicity which may enhance endothelial cell growth. XPS analysis showed a reduction 
in C-C/C-H bonding and increase in C=O bonding showing oxidation of the surface.
Adhesion tests on smooth stainless steel wire showed some delamination at only 50 % strain. 
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Figure 1: (a) uncoated versus coated, (b) 3 mm, 5 mm, and (c) 15 mm encased stents. 
Figure 2: Circumferential (hoop) stress in a thin walled tube due to internal pressure P. 
Figure 3: Cross-section of encased stent showing expansion from a to b and then recoiling 
back to final equilibrium at C after deflation of the balloon. 
Figure 4: (a) Schematic of plasma modification apparatus. (b) Polyurethane film ready for 
modification. 
Figure 5: (a) Schematic side view of carrier for stretched films. (b) Polyurethane film 
stretched 225 % showing 10 glycerol drops for contact angle measurements. 
Figure 6: Schematic of 500 tm stainless steel wire encased in polyurethane film. 
Figure 7: Optical images of polyurethane coated staihiess steel wire. (a) - (d) topside. (e) - 
(f) underside. 
Figure 8: Stress/strain curves for polyurethane films as a function of film thickness. The 
stress is plotted as the load per mm of the film width. 
Figure 9: Plot of force required to strain a polyurethane film to 225 % as a function of film 
thickness. The force is plotted as the load per mm of film width. 
Figure 10: XPS spectra of the carbon is peak before and after plasma modification showing 
the component peaks.	 - 
Figure 11: Zisman plot of PTFE and untreated polyurethane. 
Figure 12: Zisman plot of untreated polyurethane as-received and strained to 100 and 225 % 
elongation. 
Figure 13: Zisman plot of untreated and He+ plasma treated polyurethane as-received and 
after straining to 225 % elongation.
Figure 14: Optical images of a polyurethane coated wire while straining to 50 % elongation 
at 37 °C.
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Table 1: Plasma modified surface carbon curve deconvolution summary 
C-C C-N C-O C=O O-C=O it - 7t* 
Asreceived 58.7 10.0 21.7 0.88 5.7 3.0 
He+4mins. 57.0 10.8 21.7 2.6 4.8 3.2 
He+6mins 56.5 10.7 22.0 2.7 4.9 3.1
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